Business · 04/04/2019
FDA Clears CORTISPORIN Otic Solution for Continued Sale
The FDA has determined that CORTISPORIN otic solution, a medication used to treat ear infections, will not be withdrawn from sale due to safety or effectiveness concerns, allowing it to remain available for patients.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →